View Grant Opportunity
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
RFA-CA-27-001
HHS-NIH11
General Information
$5,100,000
Est. Program Funding:
Est. Program Funding:
November 10, 2026
Closing Date:
Closing Date:
20
Expected No. of Awards
Expected No. of Awards
$150,000
Award Ceiling
Award Ceiling
Opportunity Number:
RFA-CA-27-001
Owning Agency:
HHS-NIH11
Opportunity Category:
Discretionary (D)
Synopsis
| Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research. The NOFO solicits R61 applications for early-stage projects proposing proof-of-concept/pilot studies to test the technical feasibility of the proposed method, tool, assay, platform, or instrument. Technologies proposed for development may have potential for widespread applicability but must be focused for this program on cancer-relevant use cases. Projects proposing to apply or use existing technologies for hypothesis-driven research where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. | |
| Response Date | Nov 10, 2026 12:00:00 AM EST |
| Posting Date | Jun 03, 2026 12:00:00 AM EDT |
| Archive Date | Jan 09, 2027 12:00:00 AM EST |
| Award Ceiling | 150,000 |
| Award Floor | N/a |
| Cost Sharing | No |
Eligibility
| Eligible Applicants | Public housing authorities/Indian housing authorities, State governments, Others (see text field entitled "Additional Information on Eligibility" for clarification), Special district governments, City or township governments, Public and State controlled institutions of higher education, For profit organizations other than small businesses, Private institutions of higher education, County governments, Native American tribal governments (Federally recognized), Independent school districts, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Small businesses |
| Additional Info on Eligibility: | Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name | National Institutes of Health |
| Link to Additional Information: | N/a |
| Grantor Contact Information: |
If you have difficulty accessing the full announcement electronically, please contact:
GrantSolutions Help Desk Phone: 301-402-2541 |
CFDA Program(s)
- 93.394: Cancer Detection and Diagnosis Research
Contact Us
Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.